Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- A.M. Vitals: Roche Cancer Drugs Show Positive Results
- A.M. Vitals: Roche Gearing Up for Generic Battle
- A.M. Vitals: Roche Lowers Sales Forecast for Avastin
- A.M. Vitals: Roche Third-Quarter Sales Fell 7.3%
- A.M. Vitals: Roche Will Get Hearing on Avastin For Breast Cancer
- A.M. Vitals: Room For Compromise on Contraception Coverage?
- A.M. Vitals: Ryan, Wyden to Introduce Proposal for Changing Medicare
- A.M. Vitals: Salmonella-Tainted Ground Turkey Now Implicated in 107 Illnesses
- A.M. Vitals: Samsung Says Report Shows No Cancer Link to Factories
- A.M. Vitals: Sanofi (Again) Presses Genzyme to Talk
- A.M. Vitals: Sanofi Extends Offer for Genzyme; Few So Far Have Bitten
- A.M. Vitals: Sanofi Getting Financing Ready for Genzyme Bid
- A.M. Vitals: Sanofi Likely to Formally Offer to Buy Genzyme
- A.M. Vitals: Sanofi May Pay $74 Per Share Up Front for Genzyme
- A.M. Vitals: Sanofi Reports Breast Cancer Drug Setback
- A.M. Vitals: Sanofi Suggests Working Group to Look at Genzyme’s MS Drug
- A.M. Vitals: Sanofi, Genzyme Hope to (Finally) Ink Deal This Week
- A.M. Vitals: Sanofi, Genzyme Still Working on Deal Price
- A.M. Vitals: Sanofi’s 2011 Outlook Disappoints Investors
- A.M. Vitals: Scientists Stop or Delay Age-Related Diseases in Mice
- A.M. Vitals: Searching for the Source of Lung Cancer in Women
- A.M. Vitals: Secrecy in Medicare
- A.M. Vitals: Senate May Vote on Health-Care Law Repeal
- A.M. Vitals: Senators Push for Brand-Name-Friendly Biologics Policy
- A.M. Vitals: Side Effects Sideline Roche’s Experimental Diabetes Drug
- A.M. Vitals: Silicone Breast Implants Carry Risks, But Will Stay on the Market
- A.M. Vitals: Six Health-Care IPOs Planned For This Week
- A.M. Vitals: Slow Economy, Government Cuts Squeeze Nonprofit Hospitals
- A.M. Vitals: So Far, Radiation Risk in Japan is Low
- A.M. Vitals: Social Media Helped Fuel Protests Against Komen
- A.M. Vitals: Some Angioplasties Aren’t Necessary, Study Says
- A.M. Vitals: Some Japanese Food Shipments Suspended on Radiation Fears
- A.M. Vitals: Some States Move Forward Voluntarily on Health-Insurance Exchanges
- A.M. Vitals: St. Jude Medical Will Pay About $1.1 Billion for AGA Medical
- A.M. Vitals: Standing for Plaintiff in Health-Law Suit May Be in Question
- A.M. Vitals: States Can Decide on Essential Benefits for Health Plans
- A.M. Vitals: States Propose Restrictions on E-Cigarettes
- A.M. Vitals: Statin Use Associated With Lower Risk of Prostate-Cancer Death
- A.M. Vitals: Stem-Cell Experiment May Suggest Future Fertility Treatments
- A.M. Vitals: Study Highlights Value of Less Invasive Breast Cancer Treatments
- A.M. Vitals: Study Questions Genetic Test for Plavix
- A.M. Vitals: Study Suggests Calories Are Key to Fat Loss
- A.M. Vitals: Study Suggests Colonoscopy Cuts Cancer Deaths
- A.M. Vitals: Study Supports New Treatment for Severe Aortic Stenosis
- A.M. Vitals: Studying Left-Handed People For Clues to Brain Disorders
- A.M. Vitals: Supreme Court Sets Schedule for Health-Law Arguments
- A.M. Vitals: Supreme Court Sides With Generic Drug Makers
- A.M. Vitals: Supreme Court Will Hear Appeal from Mayo Clinic, But Not Pfizer
- A.M. Vitals: Supreme Court Won’t Hear Appeal in Lilly Case
- A.M. Vitals: Surgically Implanting Explosives Wouldn’t Be That Hard
- A.M. Vitals: Synthes Purchase Would Boost J&J’s Device Business
- A.M. Vitals: Takeover Target Tenet Says First-Quarter Profit Fell 16%
- A.M. Vitals: Teen Births, Food Fight, Hearing Loss
- A.M. Vitals: Teen IQs, Brains Can Change Over Time
- A.M. Vitals: Texas Board to Vote on Stem-Cell Rules
- A.M. Vitals: Texas Cuts Off Funding for Planned Parenthood
- A.M. Vitals: The iPad As Medical-Sector Sales Whiz
- A.M. Vitals: Therapists Using Dogs With Patients
- A.M. Vitals: Third Judge Says Health-Care Law is Constitutional
- A.M. Vitals: Training the Body to Grow New Parts
- A.M. Vitals: Tumor Complexity May Make Tailoring Treatment More Difficult
- A.M. Vitals: Two Execs at WellPoint Are Gone
- A.M. Vitals: Two Senators Propose Opening Medicare Database
- A.M. Vitals: U.K. Med Group Bans Wakefield; ‘Unaffordable’ Penalties May Hit Many
- A.M. Vitals: U.S. Appeals Court Hears Stem Cell Arguments
- A.M. Vitals: U.S. Lowers Bar on Lead Poisoning
- A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease
- A.M. Vitals: U.S. Officials Say Food is Safe From Radiation
- A.M. Vitals: U.S. to Match Orphaned Drugs With Researchers
- A.M. Vitals: UnitedHealth Earnings Beat Analysts’ Expectations
- A.M. Vitals: UnitedHealth Tests New Way to Reimburse Oncologists
- A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
- A.M. Vitals: Using DNA to Create Family Trees
- A.M. Vitals: Using Family History to Better Gauge Heart-Disease Risk
- A.M. Vitals: Valeant Has Approached Meda About a Takeover
2009 -